- Home
- FSP vs CDXS Comparison
FSP vs CDXS Comparison
Compare FSP & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSP | CDXS |
|---|---|---|
| Founded | 1981 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Major Chemicals |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.3M | 141.8M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | FSP | CDXS |
|---|---|---|
| Price | $0.97 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 854.0K | ★ 1.5M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | ★ 3.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $109,497,000.00 | $52,932,000.00 |
| Revenue This Year | $4.36 | $15.64 |
| Revenue Next Year | $0.81 | $5.23 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.87 | $1.52 |
| 52 Week High | $2.21 | $6.08 |
Technical Indicators
Market Signals| Indicator | FSP | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 33.51 | 46.48 |
| Support Level | $1.39 | $1.62 |
| Resistance Level | $1.04 | $1.79 |
| Average True Range (ATR) | 0.06 | 0.10 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 47.05 | 93.44 |
Price Performance
Historical ComparisonAbout FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.